Global Cancer Immunotherapy Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	180 Pages	TechNavio	July, 2024	INF19033501

Best Price Guarantee
Price	from $2,500
Length	180 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033501

Global CANCER Immunotherapy Market 2024-2028

The CANCER immunotherapy market is forecasted to grow by USD 45.5 bn during 2023-2028, accelerating at a CAGR of 8.1% during the forecast period. The report on the CANCER immunotherapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of CANCER, growing awareness among consumers regarding CANCER immunotherapy, and strong r and d pipeline of monoclonal antibodies.

Technavio's CANCER immunotherapy market is segmented as below:

By Type

Monoclonal antibodies
Check point inhibitors and immunomodulators
CANCER vaccines

By Application

Lung CANCER
Breast CANCER
Colorectal CANCER
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the adoption of various strategies for CANCER immunotherapy market growth as one of the prime reasons driving the CANCER immunotherapy market growth during the next few years. Also, emerging novel therapies for treating CANCER and availability of advanced diagnostic modalities will lead to sizable demand in the market.

The report on the CANCER immunotherapy market covers the following areas:

CANCER immunotherapy market sizing
CANCER immunotherapy market forecast
CANCER immunotherapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CANCER immunotherapy market vendors that include Amgen Inc., Amneal Pharmaceuticals Inc., AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Co., Dendreon Pharmaceuticals LLC, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline PLC, Immunocore Holdings PLC, Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi SA, Seagen Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the CANCER immunotherapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ billion); Data Table on Global - Market size and forecast 2023-2028 ($ billion); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Cancer Immunotherapy Market 2018 - 2022; Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2018 - 2022 ($ billion); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ billion); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Monoclonal antibodies - Market size and forecast 2023-2028; Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion); Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion); Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); 6.4 Check point inhibitors and immunomodulators - Market size and forecast 2023-2028; Chart on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion); Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion); Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%); Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%); 6.5 Cancer vaccines - Market size and forecast 2023-2028; Chart on Cancer vaccines - Market size and forecast 2023-2028 ($ billion); Data Table on Cancer vaccines - Market size and forecast 2023-2028 ($ billion); Chart on Cancer vaccines - Year-over-year growth 2023-2028 (%); Data Table on Cancer vaccines - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Lung cancer - Market size and forecast 2023-2028; Chart on Lung cancer - Market size and forecast 2023-2028 ($ billion); Data Table on Lung cancer - Market size and forecast 2023-2028 ($ billion); Chart on Lung cancer - Year-over-year growth 2023-2028 (%); Data Table on Lung cancer - Year-over-year growth 2023-2028 (%); 7.4 Breast cancer - Market size and forecast 2023-2028; Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion); Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion); Chart on Breast cancer - Year-over-year growth 2023-2028 (%); Data Table on Breast cancer - Year-over-year growth 2023-2028 (%); 7.5 Colorectal cancer - Market size and forecast 2023-2028; Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ billion); Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ billion); Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%); Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Application; Market opportunity by Application ($ billion); Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ billion); Data Table on North America - Market size and forecast 2023-2028 ($ billion); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ billion); Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ billion); Data Table on US - Market size and forecast 2023-2028 ($ billion); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ billion); Data Table on China - Market size and forecast 2023-2028 ($ billion); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ billion); Data Table on France - Market size and forecast 2023-2028 ($ billion); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.11 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ billion); Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; 12.4 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.5 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.6 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 12.7 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.8 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.9 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Immunocore Holdings Plc; Immunocore Holdings Plc - Overview; Immunocore Holdings Plc - Product / Service; Immunocore Holdings Plc - Key news; Immunocore Holdings Plc - Key offerings; 12.12 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.13 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; 12.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.16 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.17 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ billion); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion); Exhibits37: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion); Exhibits38: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion); Exhibits41: Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion); Exhibits42: Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Cancer vaccines - Market size and forecast 2023-2028 ($ billion); Exhibits45: Data Table on Cancer vaccines - Market size and forecast 2023-2028 ($ billion); Exhibits46: Chart on Cancer vaccines - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Cancer vaccines - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Type ($ billion); Exhibits49: Data Table on Market opportunity by Type ($ billion); Exhibits50: Chart on Application - Market share 2023-2028 (%); Exhibits51: Data Table on Application - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Application; Exhibits53: Data Table on Comparison by Application; Exhibits54: Chart on Lung cancer - Market size and forecast 2023-2028 ($ billion); Exhibits55: Data Table on Lung cancer - Market size and forecast 2023-2028 ($ billion); Exhibits56: Chart on Lung cancer - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Lung cancer - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion); Exhibits59: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion); Exhibits60: Chart on Breast cancer - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ billion); Exhibits63: Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ billion); Exhibits64: Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Application ($ billion); Exhibits71: Data Table on Market opportunity by Application ($ billion); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ billion); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Amgen Inc. - Overview; Exhibits122: Amgen Inc. - Product / Service; Exhibits123: Amgen Inc. - Key news; Exhibits124: Amgen Inc. - Key offerings; Exhibits125: AstraZeneca Plc - Overview; Exhibits126: AstraZeneca Plc - Product / Service; Exhibits127: AstraZeneca Plc - Key news; Exhibits128: AstraZeneca Plc - Key offerings; Exhibits129: Bayer AG - Overview; Exhibits130: Bayer AG - Business segments; Exhibits131: Bayer AG - Key news; Exhibits132: Bayer AG - Key offerings; Exhibits133: Bayer AG - Segment focus; Exhibits134: Bristol Myers Squibb Co. - Overview; Exhibits135: Bristol Myers Squibb Co. - Product / Service; Exhibits136: Bristol Myers Squibb Co. - Key news; Exhibits137: Bristol Myers Squibb Co. - Key offerings; Exhibits138: Eli Lilly and Co. - Overview; Exhibits139: Eli Lilly and Co. - Product / Service; Exhibits140: Eli Lilly and Co. - Key news; Exhibits141: Eli Lilly and Co. - Key offerings; Exhibits142: F. Hoffmann La Roche Ltd. - Overview; Exhibits143: F. Hoffmann La Roche Ltd. - Business segments; Exhibits144: F. Hoffmann La Roche Ltd. - Key news; Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits147: Gilead Sciences Inc. - Overview; Exhibits148: Gilead Sciences Inc. - Product / Service; Exhibits149: Gilead Sciences Inc. - Key news; Exhibits150: Gilead Sciences Inc. - Key offerings; Exhibits151: GlaxoSmithKline Plc - Overview; Exhibits152: GlaxoSmithKline Plc - Business segments; Exhibits153: GlaxoSmithKline Plc - Key news; Exhibits154: GlaxoSmithKline Plc - Key offerings; Exhibits155: GlaxoSmithKline Plc - Segment focus; Exhibits156: Immunocore Holdings Plc - Overview; Exhibits157: Immunocore Holdings Plc - Product / Service; Exhibits158: Immunocore Holdings Plc - Key news; Exhibits159: Immunocore Holdings Plc - Key offerings; Exhibits160: Johnson and Johnson Services Inc. - Overview; Exhibits161: Johnson and Johnson Services Inc. - Business segments; Exhibits162: Johnson and Johnson Services Inc. - Key news; Exhibits163: Johnson and Johnson Services Inc. - Key offerings; Exhibits164: Johnson and Johnson Services Inc. - Segment focus; Exhibits165: Merck KGaA - Overview; Exhibits166: Merck KGaA - Business segments; Exhibits167: Merck KGaA - Key news; Exhibits168: Merck KGaA - Key offerings; Exhibits169: Merck KGaA - Segment focus; Exhibits170: Novartis AG - Overview; Exhibits171: Novartis AG - Business segments; Exhibits172: Novartis AG - Key news; Exhibits173: Novartis AG - Key offerings; Exhibits174: Novartis AG - Segment focus; Exhibits175: Pfizer Inc. - Overview; Exhibits176: Pfizer Inc. - Product / Service; Exhibits177: Pfizer Inc. - Key news; Exhibits178: Pfizer Inc. - Key offerings; Exhibits179: Sanofi SA - Overview; Exhibits180: Sanofi SA - Business segments; Exhibits181: Sanofi SA - Key news; Exhibits182: Sanofi SA - Key offerings; Exhibits183: Sanofi SA - Segment focus; Exhibits184: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits185: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits186: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits187: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits188: Inclusions checklist; Exhibits189: Exclusions checklist; Exhibits190: Currency conversion rates for US$; Exhibits191: Research methodology; Exhibits192: Information sources; Exhibits193: Data validation; Exhibits194: Validation techniques employed for market sizing; Exhibits195: Data synthesis; Exhibits196: 360 degree market analysis; Exhibits197: List of abbreviations